Review Topical Sections

Dietary influence on estrogens and cytokines in breast cancer

  • Breast cancer affects one out of eight women in their lifetime. Many factors contribute to the development of breast cancer, such as hereditary mutations and lifetime exposure to environmental factors, including estrogen. In addition, overweight and obesity, especially with increased waist circumference, are known to be associated with breast cancer risk. This review will summarize our understanding of the effect of diet on breast cancer incidence and progression. Since some inflammatory cytokines that are changed by a high-fat diet are known to promote the growth of breast cancer cells, these cytokines may serve as biomarkers to monitor the dietary influence for women at high risk of breast cancer and as future therapeutic targets for breast cancer treatment.

    Citation: Xin Nian, Yasuhiro Nagai, Cameron Jeffers, Kara N. Maxwell, Hongtao Zhang. Dietary influence on estrogens and cytokines in breast cancer[J]. AIMS Molecular Science, 2017, 4(3): 252-270. doi: 10.3934/molsci.2017.3.252

    Related Papers:

    [1] Luca Spiridigliozzi, Grazia Accardo, Emilio Audasso, Barbara Bosio, Sung Pil Yoon, Gianfranco Dell’Agli . Synthesis of easily sinterable ceramic electrolytes based on Bi-doped 8YSZ for IT-SOFC applications. AIMS Materials Science, 2019, 6(4): 610-620. doi: 10.3934/matersci.2019.4.610
    [2] Fahmi Astuti, Rima Feisy Azmi, Mohammad Arrafi Azhar, Fani Rahayu Hidayah Rayanisaputri, Muhammad Redo Ramadhan, Malik Anjelh Baqiya, Darminto . Employing Na2CO3 and NaCl as sources of sodium in NaFePO4 cathode: A comparative study on structure and electrochemical properties. AIMS Materials Science, 2024, 11(1): 102-113. doi: 10.3934/matersci.2024006
    [3] Christian M. Julien, Alain Mauger . Functional behavior of AlF3 coatings for high-performance cathode materials for lithium-ion batteries. AIMS Materials Science, 2019, 6(3): 406-440. doi: 10.3934/matersci.2019.3.406
    [4] Alain Mauger, Haiming Xie, Christian M. Julien . Composite anodes for lithium-ion batteries: status and trends. AIMS Materials Science, 2016, 3(3): 1054-1106. doi: 10.3934/matersci.2016.3.1054
    [5] Min Kang, Hai Zhou . Facile Synthesis and Structural Characterization of Co3O4 Nanocubes. AIMS Materials Science, 2015, 2(1): 16-27. doi: 10.3934/matersci.2015.1.16
    [6] Dinesh Rangappa, Erabhoina Hari Mohan, Varma Siddhartha, Raghavan Gopalan, Tata Narasinga Rao . Preparation of LiMn2O4 Graphene Hybrid Nanostructure by Combustion Synthesis and Their Electrochemical Properties. AIMS Materials Science, 2014, 1(4): 174-183. doi: 10.3934/matersci.2014.4.174
    [7] Leydi J. Cardenas F., Josep Ma. Chimenos, Luis C. Moreno A., Elaine C. Paris, Miryam R. Joya . Enhancing Co3O4 nanoparticles: Investigating the impact of nickel doping and high-temperature annealing on NiCo2O4/CoO heterostructures. AIMS Materials Science, 2023, 10(6): 1090-1104. doi: 10.3934/matersci.2023058
    [8] Masatoshi Sakairi, Hirotaka Mizukami, Shuji Hashizume . Effects of solution composition on corrosion behavior of 13 mass% Cr martensitic stainless steel in simulated oil and gas environments. AIMS Materials Science, 2019, 6(2): 288-300. doi: 10.3934/matersci.2019.2.288
    [9] Nahlah Challob Younus, Hussein M. Hussein . A competitive candidate for the Cu2ZnSnS4 compound in solar photocatalytic degradation of organic pollutants. AIMS Materials Science, 2025, 12(2): 380-394. doi: 10.3934/matersci.2025020
    [10] Ahmed Z. Abdullah, Adawiya J. Haider, Allaa A. Jabbar . Pure TiO2/PSi and TiO2@Ag/PSi structures as controllable sensor for toxic gases. AIMS Materials Science, 2022, 9(4): 522-533. doi: 10.3934/matersci.2022031
  • Breast cancer affects one out of eight women in their lifetime. Many factors contribute to the development of breast cancer, such as hereditary mutations and lifetime exposure to environmental factors, including estrogen. In addition, overweight and obesity, especially with increased waist circumference, are known to be associated with breast cancer risk. This review will summarize our understanding of the effect of diet on breast cancer incidence and progression. Since some inflammatory cytokines that are changed by a high-fat diet are known to promote the growth of breast cancer cells, these cytokines may serve as biomarkers to monitor the dietary influence for women at high risk of breast cancer and as future therapeutic targets for breast cancer treatment.


    Sedentary behaviour (SB) is defined as “any waking behaviour characterized by energy expenditure ≤ 1.5 metabolic equivalents (METs) while in a sitting or reclining posture” [1]. Prolonged SB is an independent risk factor for cardiovascular disease and diabetes, cancer and all-cause mortality, which is generally independent of the amount of physical activity carried out [2]. Adults may meet the daily physical activity guidelines, but still be at risk for developing ill health due to high levels of SB throughout the rest of the day [2]. Older adults are the most sedentary and inactive subetaoup of the population, self-reporting SB between 5.3 to 7.5h/d [3],[4]. The level of SB increases even more whilst in hospital, where patients spend the vast majority of the day (80–98% of the day) sitting or lying and, mostly alone [5][7]. Prolonged sitting has been observed in orthopaedic, geriatric, neurology, rehabilitation, and medical wards in hospitals [5],[8][10]. A number of barriers to mobility have been identified including patient centred reasons (e.g. due to illness, experiencing weakness, pain and fatigue, or having an intravenous line or urinary catheter), but also whole ward behaviours (such as lack of staff to assist with out of bed activities) [11].

    There is mounting evidence that people who spend time in hospital tend to adopt a much more sedentary lifestyle while in hospital and this perseveres after discharge [6],[7],[9],[12], even if they have recovered to full functional capacity and are medically stable [12]. Yet, we know that for every 10 days of bed-rest, the equivalent of 10 years of muscle ageing occurs in people over 80-years old [13]. One week of bedrest equates to a 10% loss in strength [14], and for an older person who is at threshold strength for climbing the stairs at home, or getting out of bed standing up, such loss of strength may make the difference between dependence and independence [15].

    The importance of moving more and reducing SB in hospital was the basis of the 2016 social media campaign #endpjparalysis (http://www.endpjparalysis.com). The campaign was a call to action for NHS staff to consider ways they could support patients to maintain some normality in their routine and get up, out of their pyjamas or dressing gowns and get dressed; the idea behind it was that if people were up and dressed, they would get moving, which in turn would prevent complications associated with prolonged immobility. The social media campaign #endpjparalysis has been very successful, with 23 million Twitter impressions across many countries. Most of the people engaged in this campaign are staff working in acute hospital provision, with nurses, allied health professionals and medics considering how they can encourage their in-patients to be more active in hospital. To date though, no one has evaluated whether this or other similar initiatives are successful in getting patients moving more while in hospital. Thus, the aim of this project was to assess, in a pragmatic setting and via means of device-based measurement of physical activity and SB, whether getting up and dressed or even having a personalised “mobility plan” while in hospital, reduces SB and increases movement in ward-based patients.

    The participants for this study were recruited from a Scottish Hospital situated in a rural location, Kello Hospital (NHS Lanarkshire), which provides care for acute medical patients, rehabilitation and palliative care. Patients are admitted to Kello Hospital either from home via their General Practitioner or are transferred from a regional Acute Hospital for a period of rehabilitation. Reasons for admission include reduced mobility/frailty, falls, post-operative care (e.g. hip/knee replacement), stroke, infection (e.g. chest infection/urinary tract infection), exacerbation of a long-term condition such as Parkinson's disease or COPD, and symptom management of disease. The hospital has 17 beds and normally 2–3 beds are occupied by people from the local community with palliative care needs. Medical cover for the hospital is provided by the local General Practitioners.

    Upon admission to the hospital, ward-based patients were considered for this study if they were mobile (we excluded those who required substantial external assistance with mobility) and medically stable (i.e. they were not on palliative care or confined to bed due to an acute period of illness , and therefore not fit to participate in activity). The study volunteers were recruited to the study by the Hospital's Occupational Therapist (OT), data were collected by the OT between April and November 2017. The study followed a quality improvement design and thus a formal ethics approval was not required as per the HQIP quality improvement ethics guidance [16], which is in line with the NHS National Research Ethics Service (NRES) guidance and was confirmed in writing by the NHS Lanarkshire Research and Development Manager.

    Routinely collected data such as age, sex, length of hospital stay and the Scottish Index of Multiple Deprivation (SIMD) based on postcode classification [17] were collected for each patient. The SIMD is an official tool for identifying areas of multiple deprivation in Scotland that combines seven different domains of deprivation: income, employment, education, health access to services, crime and housing. A patient's postcode can be used to determine whether he or she lives in an area that is deemed most deprived (SIMD 1) or least deprived (SIMD 5) [17]. The researchers carrying out the analysis of the data did not have access to the patients' medical notes.

    The activPAL3 (PAL Technologies Ltd, Glasgow, UK) is a small, single unit, tri-axial accelerometer-based system that measures activity for up to 14 days. It is worn on the front of the thigh, under clothing; it is worn continuously (including overnight) and is waterproof and thus does not need to be removed during water based activities or bathing. For the purposes of this study, the OT waterproofed the monitor (heat-sealed in lay flat tubing) and secured the monitor onto each participant's thigh (PALstickie adhesive pad, covered by Opsite waterproof dressing) [18]. The OT placed the accelerometer on any new patients who were eligible for the study every Tuesday morning, and removed it and downloaded the data every Friday leading to four days of data for analysis. This approach was based on pragmatic considerations, balancing convenience in ward routine with minimising participant burden.

    The activPAL uses thigh inclination to distinguish postural sitting (from standing), and proprietary software classifies posture as sitting/lying (sedentary behaviour), standing or walking (upright movement). The activPAL is > 98% accurate in defining sitting and standing against observation in adults [19],[20] and older adults [21] and has been used in large studies to monitor and define SB [22],[23].

    Interventions designed to get patients up and moving were introduced sequentially in an additional manner (following a quality improvement methodology [24]). Participants were grouped based on the highest level of intervention they received during the time they were assessed, which depended on the date they were admitted to hospital. There were four groups: “control” (no intervention), “education” (advice on SB reduction via infographics on the ward noticeboards), “#endpjparalysis” (patients were up and dressed by the nurses before 11:30 am), “personalised activity passports” (agreed by Occupational Therapists (OT) and other members of a multidisciplinary team with patients on SB reduction).

    In brief, data for the control group were collected during the month of April 2017; in May 2017 “#ThinkActivity Board” was introduced in the ward, this included information/infographics on the importance of keeping active during a hospital stay, and data for the “education” group were collected until July 2017. The “#ThinkAcrivity Board” was created by one the authors (LMcI) based on improvement science and evidence around providing information to staff and patients.

    The board was visible at the front door of the hospital, with information on the project and the importance of improving activity on the ward. It was updated on a monthly basis to include feedback comments from patients and staff about why activity mattered to them and the challenges associated with changing physical activity levels and reducing SB. A list of all the ward-based physical activity initiatives was also posted on the board, detailing all the formal activities on offer each day at the ward (such as chair based exercise classes, bingo etc.).

    By August 2017, all nurses and staff had been trained in the importance of reducing SB and were delivering the “#endPJparalysis” intervention. This intervention based on the 2016 social media campaign #endpjparalysis (http://www.endpjparalysis.com) aimed to have all patients on the ward up and dressed by 11:30 am at the latest, this was refined to 10:30 am as part of the “plan, do, study, act” cycles of the quality improvement methodology [25].

    By September 2017, the final intervention was delivered, where patients had “personalised activity passports” [26] which involved custom-made advice agreed by OTs and other members of the multidisciplinary team with patients on SB reduction. The “personalised activity passports” were designed in collaboration with the OT and physiotherapist on the ward and with input from patients. They consist of a booklet that contains information about each patient's normal sleeping and waking routines (including activities that each patient enjoys or dislikes, and whether they prefer a group setting or individual activities). Based on that information and discussion with the patient, the OT or the physiotherapist helped each patient to devise an individualised plan of action aiming to reduce SB and increase physical activity based on personal preferences. This included a pledge to break SB and stand up regularly at an agreed frequency (e.g. every hour). The patients then had to implement the agreed “personalised activity passport” for a week and record their daily activity and exercise using visual analogue clocks incorporated in their booklets.

    Data from the activPAL were downloaded and categorised using proprietary software (PALtechnologies version 7.2.32). The activity profile for every individual over the 4 days of monitoring was inspected, and all abnormal periods of activity that appeared out of character for the individual were identified. Examples of these included protracted periods of standing during the night or prolonged uninterrupted sedentary spells during daytime in an individual who, on other days, changed position regularly. The raw accelerations signals for the abnormal periods were inspected in detail, and cross-checked against the notes that the OT kept for each participant while in the study, and if the acceleration signal remained constant throughout, the monitor was considered to have been attached incorrectly and the data was excluded from the analysis.

    In this study, the time period between 6am and 11pm was classified as “waking hours” based on ward routines and visual inspection of activity patterns in the baseline data. Outcome measures were calculated from the activPAL monitor using a custom Excel macro as per Dall et al (2017) [27]. An event is defined as a single continuous period of a single posture or activity [28]. For each participant, the following outcomes were calculated for the waking day: total upright time (standing and walking), total sitting time, the number of sitting events (i.e. the number of sit-to-stand transitions), and the duration of the longest upright period. ANOVA with post hoc test was employed to assess differences between the 4 groups. Significance was set at p < 0.05 for all testing procedures. All analyses were performed using SPSS Statistics version 23.

    The waking hours activity was examined further. The length of each upright and sedentary event during the waking day was determined for all participants in each group and was assigned to a time category (< 5 mins, 5–10 mins, 10–30 mins, 30–60 mins and > 60 mins). Events crossing the start (6 am) and end (11 pm) of the waking day were cut at that point. For each group, the total time spent upright in each category of event was calculated as a percentage of the total time upright. This procedure was repeated for sedentary time.

    In total, 43 patients took part in the study. The demographic details of the participants in each successive intervention group are presented in Table 1. Data from six patients were excluded from the analysis upon inspection of the abnormal acceleration signals that indicated that the monitor had not been attached correctly or had been removed early.

    Table 1.  Participant characteristics according to group.
    ALL (n = 43) Control (n = 12) Education (n = 12) #endpjparalysis (n = 9) Personalised activity passport (n = 10)
    Male/female (n)
    [% female]
    17/26
    [60]
    5/7
    [58]
    5/7
    [58]
    4/5
    [55]
    3/7
    [70]
    Age (years) mean (SD) 83.8 (8.3) 81.6 (5.2) 85.7 (6.6) 87.7 (9.5) 80.5 (10.6)
    SIMD1 (%) categories 1 to 5 9, 23, 16, 40, 12 0, 33, 25, 12, 25 17, 17, 8, 58, 0 0, 22, 11, 56, 11 20, 20, 20, 30, 10
    Total length of stay (days) mean (SD) 57.9 (33.5) 73.8 (39.9) 48 (32.1) 52.3 (32.7) 54.3 (10.3)

    1 SIMD: Scottish Index of Multiple Deprivation (1: most deprived, 5: least deprived).

     | Show Table
    DownLoad: CSV

    The daily upright (standing and walking) time for each group is presented in Table 2. Ward patients spent just over an hour upright during waking hours, and there were no differences between the 4 intervention groups for upright and sedentary time.

    Table 2.  Average daily upright and sedentary time (min) according to group–mean (SD).
    Upright time (min) Longest upright period (min) Sedentary time (min) Number of sitting events1
    Mean (SD)
    [min–max]
    Mean (SD)
    [min–max]
    Mean (SD)
    [min–max]
    Mean (SD)
    [min–max]
    Control (n = 12) 72 (72)
    [24–252]
    23 (18)
    [7–65]
    852 (90)
    [672–942]
    22 (16)
    [7–65]
    Education (n = 12) 78 (60)
    [12–228]
    21 (14)
    [5–48]
    834 (54)
    [714–918]
    22 (12)
    [9–51]
    #endpjparalysis (n = 9) 96 (96)
    [12–282]
    24 (27)
    [4–88]
    846 (108)
    [648–990]
    28 (15)
    [9–55]
    Personalised activity care plan (n = 10) 60 (42)
    [18–174]
    27 (19)
    [5–57]
    846 (78)
    [756–894]
    18 (7)
    [8–32]
    ANOVA p 0.700 0.915 0.989 0.418

    1 Number of sitting events is equivalent to number of sit-to-stand transitions (± 1).

     | Show Table
    DownLoad: CSV

    There were no notable differences in length of sedentary and upright events throughout the day (6 am to 11 pm) between the different 4 groups (Figure 1).

    Figure 1.  (a) Control, (b) education, (c)#endpjparalysis, and (d) personalised activity care plan upright and sedentary time represented by event length (mean (SD)).

    It appears that regardless of intervention groups, 70–80% of total upright time was accrued in short standing or walking events of less than 5 mins duration. Upright events lasting more than 1h were responsible for only 3–6% of total upright time. SB reveals an inverse pattern, in which most sitting or lying time (70–80%) was accumulated in sedentary periods longer than an hour. Shorter sitting events were responsible for only a small amount of the total sedentary time. Neither the number of sitting events (i.e. sit to stand transitions), nor the longest upright period were different between the 4 intervention groups (ANOVA p = 0.418 and 0.915 respectively, Table 2).

    This small explorative study of hospital based patients identified that current initiatives did not decrease SB or increase time spent upright (standing and walking). The cross-sectional nature of the study limited the ability to assess change in individuals as interventions were introduced. These initiatives, introduced sequentially, aimed to change behaviour in both staff and patients. They included changes to knowledge of hospital staff (through infographic posters on the ward), changes to whole-ward behaviour (using the #endpjparalysis movement, getting patients dressed earlier in the day), and individualised plans to reduce and break-up SB.

    The amount of the SB of the hospital-based patients in this study (83% to 88% of waking hours across the groups) was similar to that found in other studies in which SB was measured using devices (80–98%) [5][7], in a range of healthcare settings in developed countries. The number of sitting events (effectively equivalent to the number of sit to stand transitions) in this study (mean of 18 to 28 across 17 hours) was broadly similar to other hospital-based patients in Scotland (mean 36 across 24 hours) [29], if the difference in hours measured is taken into consideration. Additionally, the distribution of duration of SB events (generally long) and upright events (generally short) was similar to that of other hospital-based patients in Scotland [5].

    There was wide variability of SB within each of the groups, which may have masked individual change in response to the initiatives (although this could not be assessed in our cross-sectional design). Although the minimal detectable change for individual SB using device-based measurement may be large (∼2 hours/day) for community-dwelling older adults [30], such differences may actually be commonplace on transitioning to a hospital situation. For example, a case-study of an older adult admitted to hospital following upper limb injury, showed an extra 8 hours/day of SB (measured objectively) while she was in hospital compared to her pre-admission SB levels [10]. It is possible that, for this frail population, the number of sit-to-stand transitions in a day would be a more appropriate outcome measure. In a small (n = 23) pilot intervention to reduce SB in frail older adults (mean age 79 ± 8 years) living in sheltered housing, an increase in number of sit-to-stand transitions was associated with an increase in function (timed up and go 4 s faster, 2 more sit-to-stands in 30 s) [31]. However, in the current study, there was no difference in number of sitting events (effectively equivalent to number of sit-to-stand transitions) between groups. Future research should consider involving the family and carers as awareness and support among family members of the benefits of reducing prolonged sedentary time could translate into greater behaviour change and greater intervention fidelity.

    The strengths of this study were the use of a device-based measure of postural sitting, allowing for a relatively unbiased assessment of the difference between SB and upright behaviour, and a clear timeline for the introduction of successive initiatives. Another strength of this study, is that the interventions were co-created by all parties involved. The process involved staff and patients' input all the way, from the initial interviews which aimed to understand the current system and assess what mattered to patients and staff about participation in activity on the ward. This process allowed identification of current knowledge, awareness and barriers to implementation. It highlighted that patients wanted to move more, participate in structured exercise programmes and engage in a wider activity programme during their stay. Staff acknowledged the importance of encouraging people to be active, however, staff absence and limited time to spend individually with patients were highlighted as barriers to supporting patient participation in activity. For example, staff often used mechanical equipment to assist a patient to move rather than providing assistance to walk as it was less time consuming. Another barrier to initial implementation was staff awareness of the extent to which patients were sitting throughout the day. Presenting staff with the findings from the device-based measurement of the amount of sedentary time patients spent on the ward, allowed them to understand the issue, and engage more fully with the program during the sequential Plan, Do, Study Act (PDSA) cycles. The activity passport was well received by patients and provided them with a visual tool to see their progress over time; this has now been adopted as common practice and currently all 17 patients in Kello Hospital have an activity passport and there is now an activity programme 7 days per week.

    The main limitations of the study were the inability of the cross-sectional service-methodology design to assess individual response to the initiatives, and the absence of controlling for length of stay and reason for hospitalisation. This may have masked potential effects of the initiative within the wide range of behaviour across the groups. However, this design was necessary because of the use of improvement methodology, i.e. introducing initiatives sequentially, combined with initiatives which impacted ward routine for all patients (meaning the individual baseline was “current ward practice” and not “initial ward practice”). The study was introduced in a single ward, which meant only a small number of participants were included in each group. In addition, as this was a quality improvement study, its results cannot be generalizable to other locations, however our findings might be useful to others who may be thinking of implementing this kind of intervention in their own settings (and especially for people who may be thinking of measuring change). Finally, an arbitrary value was used for waking hours (based on ward routine and inspection of baseline data), therefore if people were awake outside of these hours, or asleep within these hours, data may not reflect individual sleep times and thus may misclassify SB as sleep or vice versa. Using diaries to record waking times may have allowed a more accurate record of waking times, however, routines of waking and sleeping may not have been simple, and patients may have needed help in completing the diaries, potentially leading to bias in reporting.

    In line with other studies, hospital-based patients in Scotland were sedentary for 80 to 90% of the waking day. The potential loss of muscle strength during a hospital stay could result in readmission or loss of independence on discharge, which means that this is an important area to tackle. The service-methodology used sequential introduced initiatives in line with current practice, but did not show any meaningful changes to SB in this small sample and in this setting. The trajectory of deconditioning/recovery and its relationship with engagement with physical activity/reducing SB is of interest and needs exploring. Further work is warranted to untangle the determinants of SB in hospital settings and implement successful interventions of sustainable SB change in this setting.

    [1] Howlader N, Noone A, Krapcho M, et al. (2015) SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD. 2015.
    [2] Tomasetti C, Li L, Vogelstein B (2017) Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355: 1330-1334. doi: 10.1126/science.aaf9011
    [3] Cancer Research UK, Statistics on preventable cancers. 2017. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/risk/preventable-cancers#heading-One
    [4] Colditz GA, Hankinson SE (2005) The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer 5: 388-396. doi: 10.1038/nrc1608
    [5] Boeke CE, Eliassen AH, Chen WY, et al. (2014) Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies. Breast Cancer Res Treat 146: 383-392. doi: 10.1007/s10549-014-3005-8
    [6] Farvid MS, Cho E, Chen WY, et al. (2014) Premenopausal dietary fat in relation to pre- and post-menopausal breast cancer. Breast Cancer Res Treat 145: 255-265. doi: 10.1007/s10549-014-2895-9
    [7] Sasaki S, Horacsek M, Kesteloot H (1993) An ecological study of the relationship between dietary fat intake and breast cancer mortality. Prev Med 22: 187-202. doi: 10.1006/pmed.1993.1016
    [8] Chlebowski RT, Blackburn GL, Thomson CA, et al. (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98: 1767-1776. doi: 10.1093/jnci/djj494
    [9] Chlebowski RT (2013) Nutrition and physical activity influence on breast cancer incidence and outcome. Breast 22 Suppl 2: S30-37.
    [10] Pierce JP, Natarajan L, Caan BJ, et al. (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298: 289-298. doi: 10.1001/jama.298.3.289
    [11] Sieri S, Chiodini P, Agnoli C, et al. (2014) Dietary fat intake and development of specific breast cancer subtypes. J Natl Cancer Inst 106.
    [12] Cao Y, Hou L, Wang W (2016) Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: A meta-analysis of prospective cohort studies. Int J Cancer 138: 1894-1904. doi: 10.1002/ijc.29938
    [13] Bagga D, Anders KH, Wang HJ, et al. (2002) Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr Cancer 42: 180-185. doi: 10.1207/S15327914NC422_5
    [14] Murff HJ, Shu XO, Li H, et al. (2011) Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. Int J Cancer 128: 1434-1441. doi: 10.1002/ijc.25703
    [15] Gago-Dominguez M, Yuan JM, Sun CL, et al. (2003) Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study. Br J Cancer 89: 1686-1692. doi: 10.1038/sj.bjc.6601340
    [16] Khankari NK, Bradshaw PT, Steck SE, et al. (2015) Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York. Cancer 121: 2244-2252. doi: 10.1002/cncr.29329
    [17] Wakai K, Tamakoshi K, Date C, et al. (2005) Dietary intakes of fat and fatty acids and risk of breast cancer: a prospective study in Japan. Cancer Sci 96: 590-599. doi: 10.1111/j.1349-7006.2005.00084.x
    [18] Kiyabu GY, Inoue M, Saito E, et al. (2015) Fish, n - 3 polyunsaturated fatty acids and n - 6 polyunsaturated fatty acids intake and breast cancer risk: The Japan Public Health Center-based prospective study. Int J Cancer 137: 2915-2926. doi: 10.1002/ijc.29672
    [19] Bagga D, Wang L, Farias-Eisner R, et al. (2003) Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 100: 1751-1756. doi: 10.1073/pnas.0334211100
    [20] Chenais B, Blanckaert V (2012) The janus face of lipids in human breast cancer: how polyunsaturated Fatty acids affect tumor cell hallmarks. Int J Breast Cancer 2012: 712536.
    [21] Schwingshackl L, Hoffmann G (2016) Does a Mediterranean-Type Diet Reduce Cancer Risk? Curr Nutr Rep 5: 9-17. doi: 10.1007/s13668-015-0141-7
    [22] van den Brandt PA, Schulpen M (2017) Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis. Int J Cancer 140: 2220-2231. doi: 10.1002/ijc.30654
    [23] Pot GK, Stephen AM, Dahm CC, et al. (2014) Dietary patterns derived with multiple methods from food diaries and breast cancer risk in the UK Dietary Cohort Consortium. Eur J Clin Nutr 68: 1353-1358. doi: 10.1038/ejcn.2014.135
    [24] Toledo E, Salas-Salvado J, Donat-Vargas C, et al. (2015) Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial: A Randomized Clinical Trial. JAMA Intern Med 175: 1752-1760. doi: 10.1001/jamainternmed.2015.4838
    [25] Farvid MS, Chen WY, Michels KB, et al. (2016) Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study. BMJ 353: i2343.
    [26] Liu Y, Colditz GA, Cotterchio M, et al. (2014) Adolescent dietary fiber, vegetable fat, vegetable protein, and nut intakes and breast cancer risk. Breast Cancer Res Treat 145: 461-470. doi: 10.1007/s10549-014-2953-3
    [27] Dam MK, Hvidtfeldt UA, Tjonneland A, et al. (2016) Five year change in alcohol intake and risk of breast cancer and coronary heart disease among postmenopausal women: prospective cohort study. BMJ 353: i2314.
    [28] Dong JY, Qin LQ (2011) Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies. Breast Cancer Res Treat 126: 287-294. doi: 10.1007/s10549-011-1343-3
    [29] Inoue-Choi M, Sinha R, Gierach GL, et al. (2016) Red and processed meat, nitrite, and heme iron intakes and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer 138: 1609-1618. doi: 10.1002/ijc.29901
    [30] Touvier M, Fassier P, His M, et al. (2015) Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr 114: 347-357. doi: 10.1017/S000711451500183X
    [31] Tornberg SA, Holm LE, Carstensen JM (1988) Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 27: 31-37. doi: 10.3109/02841868809090315
    [32] Vatten LJ, Foss OP (1990) Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 50: 2341-2346.
    [33] Furberg AS, Jasienska G, Bjurstam N, et al. (2005) Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 14: 33-40.
    [34] Ha M, Sung J, Song YM (2009) Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes Control 20: 1055-1060. doi: 10.1007/s10552-009-9301-7
    [35] Kitahara CM, Berrington de Gonzalez A, Freedman ND, et al. (2011) Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 29: 1592-1598. doi: 10.1200/JCO.2010.31.5200
    [36] Li C, Yang L, Zhang D, et al. (2016) Systematic review and meta-analysis suggest that dietary cholesterol intake increases risk of breast cancer. Nutr Res 36: 627-635. doi: 10.1016/j.nutres.2016.04.009
    [37] McDonnell DP, Park S, Goulet MT, et al. (2014) Obesity, cholesterol metabolism, and breast cancer pathogenesis. Cancer Res 74: 4976-4982. doi: 10.1158/0008-5472.CAN-14-1756
    [38] Reeves GK, Pirie K, Beral V, et al. (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335: 1134. doi: 10.1136/bmj.39367.495995.AE
    [39] Renehan AG, Zwahlen M, Egger M (2015) Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 15: 484-498. doi: 10.1038/nrc3967
    [40] Baumgartner KB, Hunt WC, Baumgartner RN, et al. (2004) Association of body composition and weight history with breast cancer prognostic markers: divergent pattern for Hispanic and non-Hispanic White women. Am J Epidemiol 160: 1087-1097. doi: 10.1093/aje/kwh313
    [41] Harris HR, Willett WC, Terry KL, et al. (2011) Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst 103: 273-278. doi: 10.1093/jnci/djq500
    [42] Jiralerspong S, Goodwin PJ (2016) Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. J Clin Oncol 34: 4203-4216. doi: 10.1200/JCO.2016.68.4480
    [43] Arce-Salinas C, Aguilar-Ponce JL, Villarreal-Garza C, et al. (2014) Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients. Breast Cancer Res Treat 146: 183-188. doi: 10.1007/s10549-014-2977-8
    [44] Printz C (2014) Obesity associated with higher mortality in women with ER-positive breast cancer. Cancer 120: 3267. doi: 10.1002/cncr.29079
    [45] Ottobelli Chielle E, de Souza WM, da Silva TP, et al. (2016) Adipocytokines, inflammatory and oxidative stress markers of clinical relevance altered in young overweight/obese subjects. Clin Biochem 49: 548-553. doi: 10.1016/j.clinbiochem.2016.01.003
    [46] Bulun SE, Chen D, Moy I, et al. (2012) Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab 23: 83-89. doi: 10.1016/j.tem.2011.10.003
    [47] Creighton CJ, Sada YH, Zhang Y, et al. (2012) A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat 132: 993-1000. doi: 10.1007/s10549-011-1595-y
    [48] Perks CM, Holly JM (2011) Hormonal mechanisms underlying the relationship between obesity and breast cancer. Endocrinol Metab Clin North Am 40: 485-507, vii. doi: 10.1016/j.ecl.2011.05.010
    [49] Vadgama JV, Wu Y, Datta G, et al. (1999) Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 57: 330-340. doi: 10.1159/000012052
    [50] Kaaks R, Lundin E, Rinaldi S, et al. (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13: 307-316. doi: 10.1023/A:1015270324325
    [51] Sugumar A, Liu YC, Xia Q, et al. (2004) Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111: 293-297. doi: 10.1002/ijc.20253
    [52] Renehan AG, Harvie M, Howell A (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 13: 273-278. doi: 10.1677/erc.1.01219
    [53] Endogenous H, Breast Cancer Collaborative G, Key TJ, et al. (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11: 530-542. doi: 10.1016/S1470-2045(10)70095-4
    [54] Rinaldi S, Peeters PH, Berrino F, et al. (2006) IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13: 593-605. doi: 10.1677/erc.1.01150
    [55] Allen NE, Roddam AW, Allen DS, et al. (2005) A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 92: 1283-1287. doi: 10.1038/sj.bjc.6602471
    [56] Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, et al. (2005) Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 14: 48-52.
    [57] Schairer C, Hill D, Sturgeon SR, et al. (2004) Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer 108: 773-779. doi: 10.1002/ijc.11624
    [58] Signori C, DuBrock C, Richie JP, et al. (2012) Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial. Eur J Clin Nutr 66: 878-884. doi: 10.1038/ejcn.2012.60
    [59] Kabat GC, Kim M, Caan BJ, et al. (2009) Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 125: 2704-2710. doi: 10.1002/ijc.24609
    [60] Goodwin PJ, Ennis M, Pritchard KI, et al. (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30: 164-171.
    [61] Sun W, Lu J, Wu S, et al. (2016) Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women. Am J Cancer Res 6: 2334-2344.
    [62] Lee JO, Kim N, Lee HJ, et al. (2016) Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer cells through ERM activation. Sci Rep 6: 18923. doi: 10.1038/srep18923
    [63] Sun CA, Wu MH, Chu CH, et al. (2010) Adipocytokine resistin and breast cancer risk. Breast Cancer Res Treat 123: 869-876. doi: 10.1007/s10549-010-0792-4
    [64] Dalamaga M, Sotiropoulos G, Karmaniolas K, et al. (2013) Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clin Biochem 46: 584-590.
    [65] Georgiou GP, Provatopoulou X, Kalogera E, et al. (2016) Serum resistin is inversely related to breast cancer risk in premenopausal women. Breast 29: 163-169. doi: 10.1016/j.breast.2016.07.025
    [66] Rahbar AR, Nabipour I (2014) The relationship between dietary lipids and serum visfatin and adiponectin levels in postmenopausal women. Endocr Metab Immune Disord Drug Targets 14: 84-92. doi: 10.2174/1871530314666140527143009
    [67] Dalamaga M, Karmaniolas K, Papadavid E, et al. (2011) Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters. Menopause 18: 1198-1204. doi: 10.1097/gme.0b013e31821e21f5
    [68] Lee YC, Yang YH, Su JH, et al. (2011) High visfatin expression in breast cancer tissue is associated with poor survival. Cancer Epidemiol Biomarkers Prev 20: 1892-1901. doi: 10.1158/1055-9965.EPI-11-0399
    [69] Kim SR, Park HJ, Bae YH, et al. (2012) Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion. Endocrinology 153: 554-563. doi: 10.1210/en.2011-1413
    [70] Li C, Li J, Chen Y, et al. (2016) Effect of curcumin on visfatin and zinc-alpha2-glycoprotein in a rat model of non-alcoholic fatty liver disease. Acta Cir Bras 31: 706-713. doi: 10.1590/s0102-865020160110000001
    [71] Gao Y, Wang C, Pan T, et al. (2014) Impact of metformin treatment and swimming exercise on visfatin levels in high-fat-induced obesity rats. Arq Bras Endocrinol Metabol 58: 42-47. doi: 10.1590/0004-2730000002840
    [72] Maffei M, Halaas J, Ravussin E, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161. doi: 10.1038/nm1195-1155
    [73] Thompson HJ, Sedlacek SM, Wolfe P, et al. (2015) Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors. Nutrients 7: 5156-5176. doi: 10.3390/nu7075156
    [74] Alshaker H, Wang Q, Frampton AE, et al. (2015) Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer. Breast Cancer Res Treat 149: 59-67. doi: 10.1007/s10549-014-3228-8
    [75] Park HS, Park JY, Yu R (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69: 29-35. doi: 10.1016/j.diabres.2004.11.007
    [76] Bowers LW, Brenner AJ, Hursting SD, et al. (2015) Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production. Breast Cancer Res Treat 149: 49-57. doi: 10.1007/s10549-014-3223-0
    [77] Imayama I, Ulrich CM, Alfano CM, et al. (2012) Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 72: 2314-2326. doi: 10.1158/0008-5472.CAN-11-3092
    [78] Gao D, Rahbar R, Fish EN (2016) CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells. Open Biol 6.
    [79] Svensson S, Abrahamsson A, Rodriguez GV, et al. (2015) CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer. Clin Cancer Res 21: 3794-3805. doi: 10.1158/1078-0432.CCR-15-0204
    [80] Yaal-Hahoshen N, Shina S, Leider-Trejo L, et al. (2006) The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res 12: 4474-4480. doi: 10.1158/1078-0432.CCR-06-0074
    [81] D'Esposito V, Liguoro D, Ambrosio MR, et al. (2016) Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5. Oncotarget 7: 24495-24509.
    [82] Li BH, He FP, Yang X, et al. (2017) Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. Transl Res 180: 103-117 e104. doi: 10.1016/j.trsl.2016.08.006
    [83] Bell LN, Ward JL, Degawa-Yamauchi M, et al. (2006) Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab 291: E843-848. doi: 10.1152/ajpendo.00174.2006
    [84] Sundaram S, Freemerman AJ, Johnson AR, et al. (2013) Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer. Breast Cancer Res Treat 142: 489-503. doi: 10.1007/s10549-013-2741-5
    [85] Ristimaki A, Sivula A, Lundin J, et al. (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62: 632-635.
    [86] Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84: 1188-1192. doi: 10.1054/bjoc.2000.1709
    [87] Brown KA, Simpson ER (2012) Obesity and breast cancer: mechanisms and therapeutic implications. Front Biosci (Elite Ed) 4: 2515-2524.
    [88] Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 105 Suppl 1: S52-73.
    [89] Cuzick J, Warwick J, Pinney E, et al. (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103: 744-752. doi: 10.1093/jnci/djr079
    [90] Kaaks R, Bellati C, Venturelli E, et al. (2003) Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 57: 1079-1088. doi: 10.1038/sj.ejcn.1601647
    [91] Wei M, Brandhorst S, Shelehchi M, et al. (2017) Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med 9.
    [92] Sandhu N, Schetter SE, Liao J, et al. (2016) Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial. Cancer Prev Res (Phila) 9: 275-282. doi: 10.1158/1940-6207.CAPR-15-0235
    [93] Sanderson M, Peltz G, Perez A, et al. (2010) Diabetes, physical activity and breast cancer among Hispanic women. Cancer Epidemiol 34: 556-561. doi: 10.1016/j.canep.2010.06.001
    [94] Irwin ML, Varma K, Alvarez-Reeves M, et al. (2009) Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev 18: 306-313. doi: 10.1158/1055-9965.EPI-08-0531
  • This article has been cited by:

    1. Erik A. Wu, Christopher S. Kompella, Zhuoying Zhu, Jungwoo Z. Lee, Steven C. Lee, Iek-Heng Chu, Han Nguyen, Shyue Ping Ong, Abhik Banerjee, Ying Shirley Meng, New Insights into the Interphase between the Na Metal Anode and Sulfide Solid-State Electrolytes: A Joint Experimental and Computational Study, 2018, 10, 1944-8244, 10076, 10.1021/acsami.7b19037
    2. Jože Moškon, Miran Gaberšček, Transmission line models for evaluation of impedance response of insertion battery electrodes and cells, 2021, 7, 26662485, 100047, 10.1016/j.powera.2021.100047
    3. Hiroki Nara, Daikichi Mukoyama, Ryo Shimizu, Toshiyuki Momma, Tetsuya Osaka, Systematic analysis of interfacial resistance between the cathode layer and the current collector in lithium-ion batteries by electrochemical impedance spectroscopy, 2019, 409, 03787753, 139, 10.1016/j.jpowsour.2018.09.014
    4. Tetsuya OSAKA, Toshiyuki MOMMA, Tokihiko YOKOSHIMA, Daikichi MUKOYAMA, Hiroki NARA, 2016, 84, 1344-3542, 979, 10.5796/electrochemistry.84.979
    5. Yanling Jin, Wenwei He, Fang Ren, Penggang Ren, Youlong Xu, High-performance symmetric lithium-ion batteries constructed with a new bi-functional electrode Li- and Mn-rich layered oxide 0.3Li2MnO3·0.7LiNi1/3Co1/3Mn1/3O2, 2019, 325, 00134686, 134932, 10.1016/j.electacta.2019.134932
    6. Bing Li, Casey M. Jones, Thomas E. Adams, Vikas Tomar, Sensor based in-operando lithium-ion battery monitoring in dynamic service environment, 2021, 486, 03787753, 229349, 10.1016/j.jpowsour.2020.229349
    7. Misako TOCHIHARA, Hiroki NARA, Tokihiko YOKOSHIMA, Toshiyuki MOMMA, Tetsuya OSAKA, Liquid Chromatography-Quadruple Time of Flight Mass Spectrometry (LC-QToF/MS) for Deterioration Analysis of Lithium-ion Battery during Storage, 2017, 85, 1344-3542, 721, 10.5796/electrochemistry.85.721
    8. Joanna Conder, Claire Villevieille, How reliable is the Na metal as a counter electrode in Na-ion half cells?, 2019, 55, 1359-7345, 1275, 10.1039/C8CC07852A
    9. Hyejeong Jeong, Jongjung Kim, Jiyong Soon, Seulki Chae, Seunghae Hwang, Ji Heon Ryu, Seung M. Oh, Degradation of surface film on LiCoO2 electrode by hydrogen fluoride attack at moderately elevated temperature, 2018, 277, 00134686, 59, 10.1016/j.electacta.2018.04.151
    10. Hendrik Hemmelmann, Julius K. Dinter, Matthias T. Elm, Thin Film NCM Cathodes as Model Systems to Assess the Influence of Coating Layers on the Electrochemical Performance of Lithium Ion Batteries, 2021, 2196-7350, 2002074, 10.1002/admi.202002074
    11. Yusuke NAKAMURA, Hiroki NARA, Seongki AHN, Toshiyuki MOMMA, Wataru SUGIMOTO, Tetsuya OSAKA, Influence of Li-salts on Cycle Durability of Sn-Ni Alloy Anode for Lithium-ion Capacitor, 2020, 88, 1344-3542, 74, 10.5796/electrochemistry.19-00055
    12. Yong Tao Zhang, Xiao Li Hu, On the Latest Development of some Typical Cathode Materials for Lithium Ion Battery, 2018, 783, 1662-9795, 137, 10.4028/www.scientific.net/KEM.783.137
    13. Hiroki Nara, Keisuke Morita, Daikichi Mukoyama, Tokihiko Yokoshima, Toshiyuki Momma, Tetsuya Osaka, Impedance Analysis of LiNi 1/3 Mn 1/3 Co 1/3 O 2 Cathodes with Different Secondary-particle Size Distribution in Lithium-ion Battery, 2017, 241, 00134686, 323, 10.1016/j.electacta.2017.04.153
    14. Olivera Lužanin, Jože Moškon, Tjaša Pavčnik, Robert Dominko, Jan Bitenc, Unveiling True Limits of Electrochemical Performance of Organic Cathodes in Multivalent Batteries through Cyclable Symmetric Cells, 2023, 6, 2566-6223, 10.1002/batt.202200437
    15. Batuhan Bal, Bertan Ozdogru, Minal Wable, Vijayakumar Murugesan, Gabriel M. Veith, Ömer Özgür Çapraz, Chemo-mechanical instabilities in lithium cobalt oxide at higher state-of-charge in Li-Ion batteries, 2024, 508, 00134686, 145223, 10.1016/j.electacta.2024.145223
    16. Kevin Scanlan, Arumugam Manthiram, Equations and electrochemical methods for measuring the interfacial charge-transfer kinetics of Li-ion battery active materials at high current densities, 2025, 520, 00134686, 145875, 10.1016/j.electacta.2025.145875
  • Reader Comments
  • © 2017 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(7132) PDF downloads(1035) Cited by(2)

Figures and Tables

Figures(1)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog